1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E6D037D0A2D6C64500258A0E0049F451
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/E6D037D0A2D6C64500258A0E0049F451?OpenDocument
18
19OpenDocument
203.215.16.238
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Field Medical Excellence

Document Excerpt: Rare Disease MSL Team Excellence: Benchmarking Roles and Staffing Levels

DB Image

ID: MD-870


Features:

10 Info Graphics

8 Data Graphics

80+ Metrics

7 Narratives


Pages/Slides: 4


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5770 “Rare Disease MSL Team Excellence: Benchmarking Roles and Staffing Levels”.

Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical


Companies Profiled:
Alexion Pharmaceuticals; Amicus Therapeutics; Astellas; Bayer; Biogen; BioMarin; Bluebird Bio; Chiesi; CSL Behring; Dompé; Galapagos; Horizon Therapeutics; Ipsen; Kyowa Kirin; Novartis; Orchard Therapeutics; Sage Therapeutics; Servier; Supernus; Takeda Pharmaceuticals; Ultragenyx; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.